Home » Topics » BioWorld Science

BioWorld Science
RSS

Korea Research Institute of Chemical Technology identifies DAPK2 inhibitors

June 6, 2018

First clinical data reported for PLX-9486 in GIST, solid tumors

June 6, 2018

Initial phase Ib results of Hu5F9-G4 with rituximab in relapsed/refractory NHL

June 6, 2018

FDA grants approval for a new indication for Alimta

June 6, 2018

EMA grants PRIME designation to AT-132 for the treatment of X-linked myotubular myopathy

June 6, 2018

Anti-IL-15 monoclonal antibody AMG-714 shows proof-of-concept in celiac disease trials

June 6, 2018

FDA grants QIDP designation to PLG-0206 as a treatment for prosthetic joint infection

June 6, 2018

Anti-IL-23 therapy with mirikizumab shows activity in ulcerative colitis trial

June 6, 2018

Researchers present first-in-human data for Bayer's BAY-1251152 in advanced cancers

June 5, 2018

CytRx launches new subsidiary Centurion Biopharma

June 5, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...